| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Grace Therapeutics, Inc.'s insiders have accumulated 11,608 shares worth roughly $24K on balance. In the past 30 days, 1 insider bought and 0 sold. Recent activity has leaned to the buy side.
Leading the buying is Opaleye Management Inc. (10% Owner), now holding an estimated $5.8M in GRCE.
Classified under Biotechnology (Health Care sector), GRCE's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 2.76M | $6.07M | +11.6K | |
| Dir | 10.0K | $22.0K | - | |
| Dir | 10.0K | $22.0K | - | |
| Dir | 10.0K | $22.0K | - | |
| Dir | 10.0K | $22.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 14, 2026 | Opaleye Management Inc.60 | 10% Owner | Buy | 11,608 | $2.09 | $24,206.16 | +0.4% | - | - | |
| Sep 25, 2023 | Kavuru Vimal | Director, 10% Owner | Buy | 676,371 | $1.85 | $1,249,933.61 | +132.2% | +26.4% | +43.8% | |
| Aug 31, 2023 | Olds Donald | Director | Buy | 381 | $2.05 | $781.05 | New | -0.5% | +27.2% |